A Study of the Safety of IMOVAX Polio™ in China

PHASE4CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

December 31, 2011

Conditions
PoliomyelitisPolio
Interventions
BIOLOGICAL

IMOVAX Polio™-Inactivated types 1, 2, and 3 poliovirus D vaccine

0.5 mL, at 2, 3, and 4 months; Intramuscular

Trial Locations (1)

Unknown

Shanghai

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY